Muskoxen Headbutts May Cause Brain Damage: Study

Researchers report molecular evidence of traumatic brain injury in headbutting animals, but other experts aren’t convinced.

Written byPatience Asanga
| 4 min read
two muskoxen headbutting
Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Muskoxen (Ovibos moschatus) and bighorn sheep (Ovis canadensis) are known for their dramatic head-to-head battles. But all that noggin-knocking has a cost, researchers from the Icahn School of Medicine at Mount Sinai in New York City say: much like people who hit their head too often, the animals exhibit signs of brain damage, including an increase in phosphorylated tau protein.

“It seems like animals like muskoxen and bighorn sheep get traumatic brain injuries,” says Icahn evolutionary biologist Nicole Ackermans, who spearheaded the study published May 17 in Acta Neuropathologica. However, outside experts tell The Scientist that more research is needed to determine whether the findings truly indicate brain damage from headbutting.

Studies have found that athletes of sports such as soccer, football, and rugby who sustain blows to the head run the risk of developing brain injuries, especially when hits are repeated over time. Such injuries have also been linked ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • black and white headshot of a woman
    Patience is a Nigeria-based freelance science journalist who writes about the environment, biotechnology, and life sciences. She is also the editor of aebsan, a student-run news outlet operated out of the University of Benin, Nigeria. Her writing has featured in aebsan, ICJS, and theGIST.
    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies